clock menu more-arrow no yes

Filed under:

Wisconsin's Adam Rockwood Diagnosed with Genetic Deficiency; Out Indefinitely

Hannah Foslien/Getty Images

The hits just seem to keep coming for Wisconsin this season. Today, Andy Baggott of the Wisconsin State Journal reported that freshman forward Adam Rockwood will be sideline indefinitely after being diagnosed with CPT II, a genetic enzyme deficiency.

What is CPT II? This is from the National Institute of Health:

Carnitine palmitoyltransferase II (CPT II) deficiency is a condition that prevents the body from using certain fats for energy, particularly during periods without food (fasting). There are three main types of CPT II deficiency: a lethal neonatal form, a severe infantile hepatocardiomuscular form, and a myopathic form.

Rockwood's condition would be the myopathic form, which NIH describes thusly:

The myopathic form is the least severe type of CPT II deficiency. This form is characterized by recurrent episodes of muscle pain (myalgia) and weakness and is associated with the breakdown of muscle tissue (rhabdomyolysis). The destruction of muscle tissue releases a protein called myoglobin, which is processed by the kidneys and released in the urine (myoglobinuria). Myoglobin causes the urine to be red or brown. This protein can also damage the kidneys, in some cases leading to life-threatening kidney failure. Episodes of myalgia and rhabdomyolysis may be triggered by exercise, stress, exposure to extreme temperatures, infections, or fasting. The first episode usually occurs during childhood or adolescence. Most people with the myopathic form of CPT II deficiency have no signs or symptoms of the disorder between episodes.

There's no "cure" for CPT II, but it is something that can be managed, largely through diet. Hopefully Rockwood is to get things under control and is able to return to the ice for the Badgers as quickly as possible.

UPDATE: Adam Rockwood's mother is optimistic Rockwood can return to the line-up soon with successful management: